Maxidex ophtalmic suspension

Maxidex Ophthalmic Suspension delivers prescription-strength anti-inflammatory support with 0.1% dexamethasone in a sterile 5 mL DROP-TAINER. This corticosteroid eye drop is formulated with 0.5% hydroxypropyl methylcellulose for a smooth suspension and is preserved with benzalkonium chloride. Designed for ophthalmic use, it’s suitable for professional guidance in clinical settings. DIN 00042560; prescription required in Canada.